Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS
Jingyi Ye,1,* Huiyi Wu,1,* Chuanli Huang,1 Wanting Lin,2 Caifeng Zhang,1 Bei Huang,2 Banyi Lu,2 Hongyu Xu,2 Xiaoling Li,3 Xiaoying Long1,41Department of Pharmaceutics, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, People’s Republic of China; 2Departmen...
Guardado en:
Autores principales: | Ye J, Wu H, Huang C, Lin W, Zhang C, Huang B, Lu B, Xu H, Li X, Long X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b8f3730ac66483daf87aad5f4fecd51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Improved Pharmacodynamic Potential of Rosuvastatin by Self-Nanoemulsifying Drug Delivery System: An in vitro and in vivo Evaluation
por: Verma R, et al.
Publicado: (2021) -
In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials
por: Diana Boraschi, et al.
Publicado: (2021) -
IN VIVO AND IN VITRO INTERACTION STUDIES OF ENALAPRIL WITH FLURBIPROFEN ON CARRAGEENAN INDUCED INFLAMMATION RATS (CIIR)
por: NAVEED,SAFILA, et al.
Publicado: (2014) -
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
por: Mariana Matias, et al.
Publicado: (2021) -
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
por: Giulia Mitola, et al.
Publicado: (2021)